HANGZHOU DAC BIOTECH CO., LTD

hangzhou-dac-biotech-co-ltd-logo

Hangzhou DAC Biotech Co., Ltd focuses on developing conjugate of monoclonal antibody and small molecular cytotoxic drugs.

#SimilarOrganizations #People #Financial #Website #More

HANGZHOU DAC BIOTECH CO., LTD

Industry:
Biotechnology Health Care Medical

Founded:
2012-12-31

Address:
Hangzhou, Zhejiang, China

Country:
China

Website Url:
http://www.dacbiotech.com

Total Employee:
101+

Status:
Active

Contact:
86-571-56050590

Email Addresses:
[email protected]

Total Funding:
1.11 B CNY

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF Apache Mobile Non Scaleable Content DigiCert SSL GlobalSign Encryption Everywhere Alibaba Apache Tomcat Coyote


Similar Organizations

gracell-biotechnologies-logo

Gracell Biotechnologies

Gracell Biotechnologies is a developer of cancer immune therapy designed to treat cancer.

knopp-biosciences-logo

Knopp Biosciences

Knopp Neurosciences is a drug discovery and development company working on treatments for neurological disorders.

novellus-logo

Novellus

Novellus is a biotechnology company working to develop engineered cellular medicines.

pilot-biotechnology-logo

Pilot Biotechnology

Pilot Biotechnology is an industrial biotechnology company engaged in the development, production, and sales of health care products.

Current Employees Featured

robert-yongxin-zhao_image

Robert Yongxin Zhao
Robert Yongxin Zhao Founder,CEO & Chairman @ Hangzhou DAC Biotech Co., Ltd
Founder,CEO & Chairman

Founder


robert-yongxin-zhao_image

Robert Yongxin Zhao

Investors List

gl-ventures_image

GL Ventures

GL Ventures investment in Series C - Hangzhou DAC Biotech Co., Ltd

citic-pe_image

CPE

CPE investment in Series C - Hangzhou DAC Biotech Co., Ltd

kwai-hung-group_image

Kwai Hung Group

Kwai Hung Group investment in Series C - Hangzhou DAC Biotech Co., Ltd

tigeryeah-capital_image

Tigeryeah Capital

Tigeryeah Capital investment in Series C - Hangzhou DAC Biotech Co., Ltd

citic-securities_image

CITIC Securities

CITIC Securities investment in Series C - Hangzhou DAC Biotech Co., Ltd

jinyongxin-investment-management_image

Jinyongxin Investment Management

Jinyongxin Investment Management investment in Series B - Hangzhou DAC Biotech Co., Ltd

huahai-yaoye_image

Huahai Yaoye

Huahai Yaoye investment in Series A - Hangzhou DAC Biotech Co., Ltd

zjkf-capital-management_image

ZJKF Capital Management

ZJKF Capital Management investment in Angel Round - Hangzhou DAC Biotech Co., Ltd

addor-capital_image

Addor Capital

Addor Capital investment in Angel Round - Hangzhou DAC Biotech Co., Ltd

betta-pharmaceuticals_image

Betta Pharmaceuticals

Betta Pharmaceuticals investment in Angel Round - Hangzhou DAC Biotech Co., Ltd

Official Site Inspections

http://www.dacbiotech.com Semrush global rank: 6.11 M Semrush visits lastest month: 1.33 K

  • Host name: 101.200.133.2
  • IP address: 101.200.133.2
  • Location: Hangzhou China
  • Latitude: 30.294
  • Longitude: 120.1619
  • Timezone: Asia/Shanghai

Loading ...

More informations about "Hangzhou DAC Biotech Co., Ltd"

HANGZHOU DAC BIOTECHNOLOGY CO.,LTD

HANGZHOU DAC BIOTECHNOLOGY Co., LTD. is a national high-tech enterprise established in December 2012. The management of the company is an entrepreneurial and innovative team of overseas high-level talents introduced …See details»

Hangzhou DAC Biotech Co., Ltd - Crunchbase

Contact Email [email protected] Phone Number 86-571-56050590 Hangzhou DAC Biotech provides an ADC drug platform with over 50 new intelligent …See details»

Our History - HANGZHOU DAC BIOTECHNOLOGY CO.,LTD

HANGZHOU DAC BIOTECHNOLOGY CO.,LTD. Several scientists in the founding team of the company have more than 20 years of experience in drug research and development.See details»

Hangzhou DAC Biotech Co., Ltd - Org Chart, Teams, …

View Hangzhou DAC Biotech Co., Ltd's up-to-date org chart, open roles, and culture details. Find executives, board members, teams, related companies, and more.See details»

Hangzhou DAC Biotech - Overview, News & Similar companies

Www.dacbiotech.com. Revenue <$5 Million. Industry Business Services General Business Services . Recent News & Media. No recent news or media. Overview ; Org Chart ; Who is Hangzhou DAC Biotech. Hangzhou DAC Biotech Co. Ltd is a company that operates in the …See details»

Hangzhou DAC Biotechnology Co., Ltd. - Drug …

Mar 8, 2025 Explore Hangzhou DAC Biotechnology Co., Ltd. with its drug pipeline, therapeutic area, technology platform, 13 clinical trials, 5 news, and 4 literature, Disease Domain:Neoplasms, Hemic and Lymphatic Diseases, …See details»

DAC Biotech 2025 Company Profile: Valuation, Funding …

DAC Biotech General Information Description. Developer of monoclonal antibody and small molecular cytotoxic drugs. The company focuses on developing conjugate of monoclonal antibody and small molecular cytotoxic drug that are …See details»

公司简介 - 杭州多禧生物科技有限公司 - dacbiotech.com

杭州多禧生物科技有限公司于2012年12月31日创立。其使命为“让原创药禧济天下”。经过10年来的研发沉淀,多禧建立了完善的adc技术平台,拥有不同阶段的30款adc药物,已成为世界adc领域不可忽视的引领者。See details»

Hangzhou DAC Biotechnology Co., Ltd. - synapse.zhihuiya.com

Mar 7, 2025 了解Hangzhou DAC Biotechnology Co., Ltd. (杭州多禧生物科技有限公司)公司的药物管线,治疗领域,技术平台,以及它的13项临床试验, 11篇新闻和4篇文献,疾病领域:肿瘤,血液及淋巴系统疾病,免疫系统疾病,内分泌与代谢疾病,技术平台:ADC,药物:重组人源化 …See details»

Dac Biotech - VentureRadar

Hangzhou Duoxi Biological Technology Co., Ltd. is a national high-tech enterprise established in December 2012. The company is committed to the... ... Find out more ...See details»

Hangzhou DAC Biotech Co., Ltd - Crunchbase Company Profile

Hangzhou DAC Biotech Co., Ltd focuses on developing conjugate of monoclonal antibody and small molecular cytotoxic drugs.See details»

The Management Team - HANGZHOU DAC BIOTECHNOLOGY …

Xiaomai Zhou, Ph.D. in Molecular and Cellular Physiology from Tufts University, USA, and a Research Fellow at Harvard Medical School. Dr. Zhou is responsible for molecular and cell biology, antibody generation and engineering, and in vitro functional evaluation of antibody …See details»

Dac Biotech - VentureRadar

Website: http://www.dacbiotech.com/ Develops and commercializes new anti-tumor monoclonal antibody conjugate (ADC) series of biological drugs through research ...See details»

DAC Biotech - Products, Competitors, Financials, Employees ...

Dacbiotech.com. Overview & Products; Financials; Founded Year 2012. Stage Series C | Alive. Total Raised $155.8M. Last Raised $155.8M | 4 yrs ago. Mosaic Score. The Mosaic Score is an algorithm that measures the overall financial health and market potential of private companies. …See details»

杭州多禧生物科技有限公司 - 顺企网

Nov 17, 2022 这里是杭州多禧生物科技有限公司在顺企网杭州黄页的介绍页,位于杭州经济技术开发区6号大街260号12幢1楼,营业范围有技术开发、技术咨询、成果转让:生物技术、医药技术、医疗诊断试剂及其设备、医药中间体;批发、零售:医药中间体;货物进出口;其他无需报 …See details»

Nextsource | Company Profile | Hangzhou DAC Biotech Co., Ltd

Explore the company profile of Hangzhou DAC Biotech Co., Ltd (dacbiotech.com) featuring business details and insights, funding data, industry info, employee numbers, and more.See details»

多禧生物-动脉网 - vbdata.cn

Dec 31, 2012 [email protected]. 杭州多禧生物科技有限公司于2012年12月31日创立。其使命为“让原创药禧济天下”。经过近10年的研发沉淀,多禧生物建立了完善的ADC技术平台,拥有不同阶段的20款ADC药物,已成为世界ADC领域不可忽视的引领者。See details»

Our Stories - HANGZHOU DAC BIOTECHNOLOGY CO.,LTD

HANGZHOU DAC BIOTECHNOLOGY Co., LTD. is a national high-tech enterprise established in December 2012. The management of the company is an entrepreneurial and innovative team of overseas high-level talents introducedby Hangzhou Economic and Technological …See details»

Hangzhou DAC Biotechnology Announces a Collaboration and …

With the aim to discover novel ADC products via license collaboration, DAC Biotechnology will fully leverage its intellectual properties and proprietary ADC platform,See details»

linkstock.net © 2022. All rights reserved